ALBEMARLE CORP (ALB) Stock
ALB has an Alpha Score of 19 out of 100 (poor), computed on Oct 31, 2026 from 3 of 4 sub-scores. 13 members of Congress disclosed 30 trades in ALB since 2015: 19 purchases and 11 sales, most recently John Boozman (purchase, May 15, 2026). 6 of the hedge funds AlphaScala tracks reported ALB in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $118.16M. Its trailing P/E ratio is 50.0 and its net margin 3.8% (key statistics as of Oct 22, 2026).
What is ALB's Alpha Score?
How it works →Alpha Score of 19 reflects poor overall profile with poor momentum, poor value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 31, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded ALBEMARLE CORP (ALB)?
Most recent: John Boozman (purchase, May 15, 2026); records start Mar 18, 2015.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| John Boozman R-AR · Senate | 2026-05-15 | purchase | $1k – $15k |
| Jefferson Shreve R-IN · House | 2025-05-12 | sale | $15k – $50k |
| Jefferson Shreve R-IN · House | 2025-04-07 | purchase | $15k – $50k |
| Jefferson Shreve R-IN · House | 2025-02-24 | sale | $15k – $50k |
| Julie Johnson D-TX · House | 2025-02-12 | sale | $1k – $15k |
| Rick Allen R-GA · House | 2023-12-21 | sale | $1k – $15k |
| Dan Goldman D-NY · House | 2023-04-10 | sale | $15k – $50k |
| Deborah Ross D-NC · House | 2021-12-28 | purchase | $15k – $50k |
From STOCK Act periodic transaction reports. House filings as of Nov 1, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all ALB political trades →Which hedge funds own ALB?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 875K | $118.16M | +382% |
| Renaissance Technologies Jim Simons (founder) | 456K | $61.59M | -38% |
| D.E. Shaw David Shaw | 131K | $17.72M | -90% |
| Bridgewater Associates Ray Dalio | 116K | $15.70M | +253% |
| Marshall Wace | 115K | $15.55M | +165% |
| Millennium Management Israel Englander | 97K | $13.08M | -81% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →What are ALB's key statistics?
Key statistics as of Oct 22, 2026
How does ALB's valuation compare with the Materials sector?
| Metric | ALB | Materials median | Companies in median |
|---|---|---|---|
| P/E ratio | 50.0 | 18.5 | 70 |
| Net margin | 3.79% | 9.00% | 78 |
| Return on equity | 2.26% | 13.06% | 81 |
| Dividend yield (payers) | 1.24% | 1.82% | 61 |
Medians over the Materials stocks whose key statistics were refreshed in the last 35 days (newest Nov 3, 2026). P/E excludes loss-making companies.
ALB price chart
Powered by TradingViewWhat does ALBEMARLE CORP do?
Albemarle Corporation is an American specialty chemicals manufacturing company headquartered in Charlotte, North Carolina, serving multiple industries including automotive and electric vehicles, aviation and aerospace, energy storage, conventional energy, and industrial processes. The company is a leading producer of essential elements, particularly lithium, bromine, and catalysts used across various sectors. Albemarle operates lithium extraction and processing facilities globally, including hard-rock and brine operations in the United States and Chile, converting raw lithium into battery-grade lithium chloride, lithium carbonate, and lithium hydroxide. The company manufactures flame-retardant chemicals, catalysts for petroleum refining, polyurethane foam products, and fine chemicals for pharmaceutical and life sciences applications. With production locations spanning North America, Europe, and Asia, Albemarle supplies customers across approximately 70 countries, supporting critical markets in mobility, energy storage, connectivity, and health sectors.